Effect of the transcutaneous electrical stimulation system on esophageal-acid exposure in patients non-responsive to once-daily proton-pump inhibitor: proof-of-concept study.

Ram DickmanSigal LevyTsachi Tsadok PeretsMaor Hazani-PaukerDoron BoltinHemda Schmilovitz-WeissIssa NidalMatan SitermanDan CarterRonnie FassRachel Gingold-Belfer

Published in: Gastroenterology report (2021)

TESS is a safe and potentially effective modality in reducing esophageal-acid exposure in GERD patients unresponsive to standard-dose PPI. A larger and prospective controlled study is needed to verify these preliminary results.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
spinal cord injury
physical activity
drug delivery
patient reported outcomes
small molecule
cancer therapy